<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046711"><TermName>PTK787/ZK 222584</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors. Also called vatalanib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PTK787/ZK 222584</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor de la proteína tirosina cinasa y de inhibidor de la proteína cinasa receptora del VEGF (factor de crecimiento endotelial vascular). También se llama vatalanib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2004-10-21</DateLastModified></GlossaryTerm>
